Citizens & Northern Corp Buys 13,860 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Citizens & Northern Corp boosted its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 69.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 33,810 shares of the company's stock after buying an additional 13,860 shares during the period. Citizens & Northern Corp's holdings in Bath & Body Works were worth $1,311,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the company. Principal Financial Group Inc. lifted its stake in shares of Bath & Body Works by 1.1% in the 4th quarter. Principal Financial Group Inc. now owns 1,081,977 shares of the company's stock valued at $41,948,000 after purchasing an additional 12,036 shares during the period. Rhumbline Advisers lifted its stake in Bath & Body Works by 38.5% in the fourth quarter. Rhumbline Advisers now owns 513,546 shares of the company's stock valued at $19,910,000 after buying an additional 142,753 shares during the period. Van ECK Associates Corp boosted its holdings in shares of Bath & Body Works by 72.7% during the 4th quarter. Van ECK Associates Corp now owns 150,285 shares of the company's stock worth $5,827,000 after buying an additional 63,253 shares in the last quarter. Louisiana State Employees Retirement System grew its position in shares of Bath & Body Works by 740.5% during the 4th quarter. Louisiana State Employees Retirement System now owns 105,900 shares of the company's stock worth $4,106,000 after buying an additional 93,300 shares during the period. Finally, Entropy Technologies LP bought a new stake in shares of Bath & Body Works in the 4th quarter valued at $1,273,000. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Stock Down 4.5 %

NYSE BBWI traded down $1.84 on Friday, reaching $38.51. The company had a trading volume of 5,441,380 shares, compared to its average volume of 3,304,652. The stock has a market capitalization of $8.34 billion, a P/E ratio of 9.39, a P/E/G ratio of 0.95 and a beta of 1.83. The company's fifty day moving average is $37.70 and its 200 day moving average is $33.86. Bath & Body Works, Inc. has a 52-week low of $26.20 and a 52-week high of $52.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter in the prior year, the company posted $0.48 earnings per share. The firm's revenue for the quarter was up 3.1% on a year-over-year basis. On average, research analysts expect that Bath & Body Works, Inc. will post 3.26 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 7th. Stockholders of record on Friday, February 21st will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.08%. Bath & Body Works's payout ratio is presently 19.51%.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. TD Cowen increased their target price on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock a "buy" rating in a research note on Thursday, December 12th. Piper Sandler increased their price objective on shares of Bath & Body Works from $36.00 to $39.00 and gave the stock a "neutral" rating in a research report on Monday, January 6th. Argus reaffirmed a "hold" rating on shares of Bath & Body Works in a research report on Friday, January 10th. Telsey Advisory Group reaffirmed an "outperform" rating and set a $43.00 price target on shares of Bath & Body Works in a research note on Thursday. Finally, JPMorgan Chase & Co. raised Bath & Body Works from a "neutral" rating to an "overweight" rating and raised their price objective for the company from $41.00 to $47.00 in a research note on Tuesday. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $43.63.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.